A Case of Recurrent Herpes Simplex Virus Disease of a Preterm Infant, Who Needed Continuous Oral Acyclovir Suppressive Therapy.
- Author:
Sung Seok KIM
1
;
Ki Woong HONG
;
Eun Ryoung KIM
;
Young Don KIM
;
Kyoo Man LEE
Author Information
1. Department of Pediatrics, Sung-Ae General Hospital, Seoul, Korea. nicu@chollian.net
- Publication Type:Case Report
- Keywords:
Herpes simplex virus;
Acyclovir;
Preterm infant;
Skin;
eyes and mouth(SEM)
- MeSH:
Academies and Institutes;
Acyclovir*;
Herpes Simplex*;
Humans;
Hypersensitivity;
Infant, Newborn;
Infant, Premature*;
Mortality;
Neurologic Manifestations;
Recurrence;
Simplexvirus*;
Skin;
Survivors
- From:Journal of the Korean Pediatric Society
2003;46(9):939-943
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Neonatal herpes simplex virus(HSV) infections result in significant morbidity and mortality. Although acyclovir treatment has improved survival, severe neurological sequelae can occur in the majority of survivors. HSV infections limited to the skin, eyes and mouth(SEM) can cause neurologic impairment. A direct correlation exists between the development of neurologic deficits and the frequency of cutaneous HSV recurrences. National Institutes of Allergy and Infectious Diseases(NIAID) Collaborative Antiviral Study Group conducted a phase I/II trial of continuous oral acyclovir therapy for the suppression of cutaneous recurrences. We describe a preterm infant who had two recurrences after neonatal SEM disease had been treated with intravenous acyclovir, and there were no more recurrences after continuous oral acyclovir suppressive therapy for six months. We report this case with a review of related literature.
